World's first pill to treat COVID-19 approved
The UK is the first in the world to approve COVID-19 pills. Writes about it with the BBC.
Molnupiravir is an experimental antiviral drug developed to treat influenza. Clinical trials have proven that it roughly halves the risk of hospitalization and death due to COVID-19.
The drug has been approved by the British Medicines and Medical Devices Agency (MHRA).
British Minister of Health Sajid Javid called this day "historic for the country."
Treatment is a game changer for patients with weakened immune systems, he said.
As noted, the pills will be given twice a day to the most vulnerable patients who have recently been diagnosed with the disease.
The first pill
Molnupiravir is a joint development of American pharmaceutical companies Merck Sharp & Dohme and Ridgeback Biotherapeutics.
It will be available as an oral tablet, not given intravenously.
The principle of the drug's action is to block the enzyme that the virus needs to reproduce the genetic code.
This should prevent it from multiplying and reduce the risk of severe disease.
Merck says the pills will be effective against new strains of coronavirus that may appear in the future.
The MHRA recommended molnupiravir to patients with moderate to mild symptoms, comorbid conditions, overweight, diabetes or heart problems, and elderly patients.
MHRA chief June Rein said the pill is “another therapeutic agent that is adding to our arsenal of COVID-19 response. It is the world's first approved antiviral for this disease that can be taken orally, rather than intravenously. And this is important because it can be used outside of hospitals even before COVID-19 becomes severe. ”
The UK has already ordered 480 courses of the drug, which should be received by the end of this year.
Experts say the drug has tremendous potential in the fight against the pandemic.
You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York
Tablets are usually easy to manufacture, transport, store, and use. This makes them an especially attractive option for countries with low and middle profit margins, weak infrastructure and limited vaccine supplies.
Based on data from 775 patients who agreed to participate in the study and took molnupiravir, the following was found:
- 7,3% of patients were hospitalized;
- of patients taking placebo, 14,1% were hospitalized;
- among those who took the experimental drugs, no one died;
- of the patients given the placebo, eight died.
This data was published in a press release from the company and has not yet been confirmed by independent reviews.
Based on the results of the study, for effective action, molnupiravir must be taken in the early stages of the onset of symptoms. Previously, manufacturers tried to conduct another study involving patients who were hospitalized with severe symptoms, but it had to be stopped because the drug did not bring tangible results.
Merck is the first company to report test results for COVID-19 pills. However, other pharmaceutical companies are also working on similar developments.
Corporation Pfizer began researching two different antiviral pills, the same drug is being developed by the Swiss Roche.
Read also on ForumDaily:
stdClass Object ([term_id] => 5356 [name] => medicine [taxonomy] => post_tag [slug] => lekarstvo)medicine
stdClass Object ([term_id] => 27233 [name] => World [taxonomy] => category [slug] => mir)World
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
stdClass Object ([term_id] => 28353 [name] => READ ABOUT CORONAVIRUS [taxonomy] => special [slug] => kitajskij-koronavirus)
stdClass Object ([term_id] => 28455 [name] => COVID-19 [taxonomy] => post_tag [slug] => covid-19)COVID-19
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram - there are many interesting things. And join thousands of readers ForumDaily Woman и ForumDaily New York - there you will find a lot of interesting and positive information.